Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].

Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology - 1 Jun 2001

Ma H, You H, Yin S

Abstract excerpt

OBJECTIVE: To study the clinical efficacy and safety of lamivudine in the treatment of chronic hepatitis B. METHODS: 72 patients with hepatitis B were randomly assigned into lamivudine (n = 54) and placebo groups (n = 18) for 12 weeks. Then, all the patients received lamivudine 100 mg daily until week 104. Clinical symptoms, liver function tests, serum HBV DNA and YMDD mutation were evaluated. RESULTS: HBV DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lamivudine
Share to Adolescent

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to DNA, Viral

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Mutation

Source

Identifiers

PMID: 11436644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].PMID 11436644Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

[Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].Semantic proximity Read ↗

[Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].Semantic proximity Read ↗

[Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].Semantic proximity Read ↗

[Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].Semantic proximity Read ↗

[Lamivudine therapy for chronic hepatitis B].Semantic proximity Read ↗

[Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].Semantic proximity Read ↗

[A study on the treatment of chronic hepatitis B with YMDD mutation].Semantic proximity Read ↗

[Lamivudine treatment for hepatitis B].Semantic proximity Read ↗

[Evaluation of Chai Shao Liu Jun Tang for the treatment of chronic hepatitis B].Semantic proximity Read ↗

[Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].Semantic proximity Read ↗

HBV genotype B/C and response to lamivudine therapy: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.